Related Experiment Video
Updated: Sep 29, 2025

Author Spotlight: Gut Microbiome-Lung Tissue Communication Through Short-Chain Fatty Acid Analysis
Published on: June 21, 2024
Short-Chain Fatty Acid Receptors and Cardiovascular Function
Anastasios Lymperopoulos1, Malka S Suster1, Jordana I Borges1
1Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences, Nova Southeastern University College of Pharmacy, Fort Lauderdale, FL 33328, USA.
Gut microbes produce short-chain fatty acids (SCFAs) that signal through SCFA receptors (SCFARS) to influence cardiovascular health. Targeting these SCFAR pathways offers potential therapeutic strategies for heart disorders.
Area of Science:
- Microbiology
- Metabolism
- Cardiovascular Physiology
Background:
- The gut microbiome significantly impacts human health, including cardiovascular disorders.
- Free fatty acids (FFAs) are energy substrates, with short-chain FFAs (SCFAs) produced by gut microbiota fermentation of dietary fiber.
- FFAs act as ligands for FFA receptors (FFARs), G protein-coupled receptors (GPCRs) regulating metabolism, immunity, and inflammation.
Purpose of the Study:
- To review the cardiovascular implications of SCFA receptor (SCFAR) signaling pathways.
- To highlight the roles of SCFARs (FFAR2 and FFAR3) in cardiovascular physiology and disease.
- To explore the therapeutic potential of SCFARs for cardiovascular disorders.
Main Methods:
- Literature review focusing on experimental and clinical evidence.
- Analysis of the physiological functions of SCFA signaling pathways.
- Discussion of neurohormonal control and adipose tissue homeostasis related to SCFARs.
Main Results:
- SCFARS (FFAR2 and FFAR3) play crucial roles in cardiovascular physiology.
- SCFAR signaling influences neurohormonal control of circulation.
- SCFAR pathways are implicated in adipose tissue homeostasis.
Conclusions:
- SCFA receptors (FFAR2 and FFAR3) are vital in cardiovascular regulation.
- Understanding SCFA signaling pathways provides insights into cardiovascular health and disease.
- Targeting SCFARs presents a promising therapeutic avenue for cardiovascular disorders.
Related Concept Videos
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
G-Protein Gated Ion Channels
Sensory...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...

